A phase I/II study of combined weekly systemic cisplatin and locoregional hyperthermia in patients with previously irradiated recurrent carcinoma of the uterine cervix

British Journal of Cancer

Volumn 80, Issue 9, 1999, Pages 1387-1391

  De Wit, R ^a   Van Der Zee, J ^a   Van Der Burg, M E L ^a   Kruit, W H ^a   Logmans, A ^a,b   Van Rhoon, G C ^a   Verweij, J ^a  

^a ERASMUS MC CANCER INSTITUTE   (Netherlands)

^b Zuiderziekenhuis   (Netherlands)

Author keywords

Cervical cancer; Cisplatin chemotherapy; Hyperthermia

Indexed keywords

CISPLATIN;

ADULT; AGED; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER RECURRENCE; CLINICAL ARTICLE; CLINICAL TRIAL; DEVICE; FEMALE; HUMAN; HYPERTHERMIC THERAPY; LEUKOPENIA; NAUSEA; NEPHROTOXICITY; NEUROTOXICITY; PHASE 1 CLINICAL TRIAL; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; TEMPERATURE; THROMBOCYTOPENIA; TINNITUS; UTERINE CERVIX CARCINOMA; VOMITING;

ADULT; AGED; CISPLATIN; COMBINED MODALITY THERAPY; FEMALE; HUMANS; HYPERTHERMIA, INDUCED; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; UTERINE CERVICAL NEOPLASMS;

EID: 0033028099     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjc.6690533     Document Type: Article

References (17)

1. Baba H, Siddik ZH, Strebel FR, Jenkings GN and Bull JMC (1989) Increased therapeutic gain of combined cisdiamminedichloroplatinum (II) and whole body hyperthermia by optimal heat scheduling in the rat. Cancer Res 49: 7041-7044
2. Brader KR, Morris M, Levenback C, Levy L, Lucas KR and Gershenson DM (1998) Chemotherapy for cervical carcinoma: factors determining response and implications for clinical trial design. J Clin Oncol 16: 1879-1884
3. Dahl O (1995) Interaction of heat and drugs in vitro and in vivo. In: Thermoradiotherapy and Thermochemotherapy, vol. 1, Seegenschmiedt MH, Fessenden P and Vernon CC (eds). pp. 103-121. Springer: Berlin
4. Green DM, Burton GV, Cox EB, Hanson D, Moore J and Oleson JR (1989) A phase I/II study of combined cisplatin and hyperthermia treatment for refractory malignancy. Int J Hyperthermia 5: 13-21
5. Hopewell JW (1983) Radiation effects on vascular tissue. In: Cytotoxic Insult to Tissue: Effect on Cell Lineages, Potten CS, Hendry JH (eds). pp. 228-257. Churchill Livingstone: Edinburgh
6. Lele SB and Piver MS (1989) Weekly cisplatin induction chemotherapy in the treatment of recurrent cervical carcinoma. Gynecol Oncol 33: 6-8
7. Osmak M and Perovic S (1989) Multiple fractions of gamma rays induced resistance to cis-dichloro diammineplatinum (II) and methotrexate in human HeLa cells. Int J Radiat Oncol Biol Phys 16: 1537-1541
8. Planting AST, van der Burg MEL, de Boer-Dennert M, Stofer G and Verweij J (1993) Phase I/II study of a short course of weekly cisplatin in patients with advanced solid tumours. Br J Cancer 68: 798-792
9. Planting AST, de Mulder PHM, de Graeff A and Verweij J (1997) Phase II study of weekly high-dose cisplatin for six cycles in patients with locally advanced squamous cell carcinoma of the head and neck. Eur J Cancer 33: 61-65
10. Potter ME, Hatch KD, Potter MY, Shingleton HM and Baker VV (1989) Factors effecting the response of recurrent squamous cell carcinoma of the cervix to cisplatin. Cancer 63: 1283-1286
11. Rietbroek RC, Bakker PJM, Schilthuis MS, Postma AJ, Zum Vörde Sive Vörding PJ, González González D, Kurth KH, Bakker AJ and Veenhof CHN (1996) Feasibility, toxicity and preliminary result of weekly locoregional hyperthermia and cisplatin in patients with previously irradiated recurrent cervical carcinoma or locally advanced bladder cancer. Int J Radiat Oncol Biol Phys 34: 887-893
12. Rietbroek RC, Schilthuis MS, Bakker PJM, Dijk van JDP, Postma AJ, González González D, Bakker AJ, van der Velden J, Helmerhorst THM and Veenhof CHN (1998) Phase II trial of weekly locoregional hyperthermia and cisplatin in patients with a previously irradiated recurrent carcinoma of the uterine cervix. Cancer 79: 935-943
13. Turner PF and Schaefermeyer T (1989) BSD-2000 approach for deep local and regional hyperthermia: clinical ulility. Strahlenther Onkol 165: 700-704
14. van der Zee J, Peer-Valstar JN, Rietveld PJM, de Graaf-Strukowska L and van Rhoon GC (1998) Practical limitations of interstitial thermometry during deep hyperthermia. Int J Radiat Oncol Biol Phys 40: 1205-1212
15. Wallner KE, de Gregorio MW and Li GC (1986) Hyperthermic potentiation of cisdamminedichloroplatinum (II) cytotoxicity in Chinese hamster ovary cells resistant to the drug. Cancer Res 46: 6242-6245
16. Wallner KE and Li GC (1987) Effect of drug exposure duration and sequencing on hyperthermic potentiation of mitomycin-C and cisplatin. Cancer Res 47: 493-495
17. WHO (1979) Handbook of Reporting Results of Cancer Treatment. WHO: Geneva